The mitochondrial membrane permeabilization (MMP) process is often altered in cancer cells possibly as a result of PTP component overexpression [19], upregulation of anti-apoptotic members of the Bcl-2 family and/or downregulation of Bax [20]. Here, BCL2 is linked to cancer.